Jasper Therapeutics, Inc. Common Stock (JSPR) is a publicly traded Healthcare sector company. As of May 21, 2026, JSPR trades at $0.87 with a market cap of $22.58M and a P/E ratio of -0.22. JSPR moved +0.00% today. Year to date, JSPR is -52.33%; over the trailing twelve months it is -82.69%. Its 52-week range spans $0.62 to $26.05. Analyst consensus is buy with an average price target of $7.88. Rallies surfaces JSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Jasper Therapeutics, Inc. Common Stock (JSPR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. JSPR moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.87 |
| Market Cap | $22.58M |
| P/E Ratio | -0.22 |
| EPS | $-3.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.05 |
| 52-Week Low | $0.62 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-75.80M |
| Gross Margin | 0.00% |
6 analysts cover JSPR: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.88.